Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 2 days ago

ANAPTYSBIO, INC: Sirenia Capital Management LP amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Sirenia Capital Management LP amended its Schedule 13G filing on AnaptysBio, Inc. with the SEC under accession number 0000919574-26-007951. The amendment updates the investment firm's previously reported beneficial ownership position in the clinical-stage biotechnology company. Schedule 13G filings are required of investors holding passive stakes above 5% of a class of registered equity securities. The revised disclosure signals a change in Sirenia's holdings, though the filing summary did not specify the exact share count or percentage. Investors will watch for the full filing details to gauge the size and direction of the stake adjustment.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

AnaptysBio, Inc., Sirenia Capital Management LP